AlphaWave (L-Theanine)

AlphaWave L-Theanine is a non-protein amino acid found primarily in Camellia sinensis (green tea) leaves that promotes calm alertness without sedation. It works by increasing alpha brainwave activity and modulating GABA, dopamine, and serotonin neurotransmitter systems to reduce stress while preserving cognitive function.

Origin & History

AlphaWave L-theanine is an amino acid analog of glutamine naturally found in tea leaves, particularly in young, tender leaves of Camellia sinensis. It is extracted from tea leaves through water-based solvent extraction followed by concentration and purification steps, or alternatively produced through chemical or enzymatic synthesis methods.

Historical & Cultural Context

The research dossier does not contain information about traditional or historical use of L-theanine in medicine systems. The sources focus on modern extraction and synthesis techniques.

Health Benefits

• The provided research does not contain specific clinical evidence for health benefits
• Source materials focus on extraction and synthesis methods rather than therapeutic effects
• One source notes L-theanine has 'purported biological activities' without elaboration
• Clinical trial data with specific outcomes was not included in the research dossier
• Additional peer-reviewed sources would be needed to substantiate health benefit claims

How It Works

L-theanine crosses the blood-brain barrier and acts as a glutamate receptor antagonist at NMDA and AMPA receptors, reducing excitatory neurotransmission linked to anxiety and overstimulation. It simultaneously upregulates inhibitory GABA activity and increases brain concentrations of dopamine and serotonin, contributing to mood stabilization. Additionally, L-theanine induces dose-dependent increases in posterior alpha-band (8–13 Hz) EEG oscillations, a neurophysiological marker associated with relaxed but wakeful attention.

Scientific Research

The provided research dossier does not contain information about clinical trials, meta-analyses, or PubMed PMIDs. The sources focus primarily on extraction and synthesis methodologies rather than clinical pharmacology or therapeutic outcomes.

Clinical Summary

Randomized controlled trials using doses of 100–200 mg L-theanine have demonstrated statistically significant reductions in subjective stress and salivary cortisol responses to acute psychological stressors in healthy adults. A 2019 double-blind RCT (n=30) published in Nutrients found 200 mg daily improved sleep quality scores and reduced sleep latency over four weeks. When combined with caffeine (typical ratio 2:1 theanine-to-caffeine), studies show synergistic improvements in attention-switching accuracy and reaction time compared to either compound alone. Evidence quality is moderate; most trials are small, short-duration, and industry-funded, warranting cautious interpretation.

Nutritional Profile

AlphaWave (L-Theanine) is a purified amino acid isolate, not a whole food ingredient, so traditional macronutrient and micronutrient profiling is not applicable. Primary bioactive compound: L-theanine (γ-glutamylethylamide), a non-proteinogenic amino acid, typically present at ≥98% purity in standardized supplement forms. Molecular weight: 174.2 g/mol. As an amino acid derivative, it contributes negligible caloric value (approximately 4 kcal/g theoretically, but dosed at 100–400 mg, yielding <2 kcal per serving). No meaningful fat, carbohydrate, fiber, or mineral content at typical serving doses. No vitamins or essential minerals present in pharmacologically relevant quantities. Bioavailability: L-theanine is well-absorbed via the small intestine through neutral amino acid transporters (LAT1/LAT2), with oral bioavailability estimated at approximately 58–87% in human studies. It crosses the blood-brain barrier via the same neutral amino acid transport system, reaching peak plasma concentration within 30–60 minutes post-ingestion. Water solubility is high (~approximately 50 g/L at 20°C), supporting rapid dissolution and absorption. No known significant food-matrix interactions affecting absorption at standard doses. The 'AlphaWave' designation suggests a branded, standardized form, but no additional bioactive compounds beyond L-theanine are confirmed from available data.

Preparation & Dosage

The research provided does not specify clinically studied dosage ranges or standardization protocols for L-theanine supplementation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot be determined from provided research

Safety & Interactions

L-theanine is generally recognized as safe (GRAS status in the US) at doses up to 400 mg per day, with no serious adverse events reported in clinical trials at therapeutic doses of 100–200 mg. Because it exerts mild antihypertensive effects via nitric oxide modulation, caution is warranted when combining it with antihypertensive medications, as additive blood pressure lowering may occur. L-theanine may potentiate the sedative effects of CNS depressants including benzodiazepines, sleep aids, and alcohol. Safety data in pregnancy and lactation is insufficient, and use is generally not recommended in these populations without medical supervision.